# SNIP1

## Overview
SNIP1 (Smad nuclear interacting protein 1) is a gene that encodes a nuclear protein involved in various cellular processes, particularly in transcriptional regulation. The protein, also referred to as SNIP1, functions primarily as a transcriptional co-repressor within the TGF-β signaling pathway. It achieves this by interacting with Smad proteins, notably Smad4, and inhibiting the formation of Smad4/p300 complexes, thereby modulating transcriptional activation. SNIP1 also plays a role in the regulation of c-MYC target genes and the cellular DNA damage response, highlighting its involvement in maintaining genomic stability and influencing epigenetic regulation. The protein's interactions with other molecules, such as the transcriptional co-activator CBP/p300 and TET2, further underscore its multifaceted role in cellular homeostasis and its potential implications in various diseases, including cancer and neurodevelopmental disorders (Chen2018SNIP1; Ammous2021A; Kim2000A).

## Structure
SNIP1 is a nuclear protein composed of 396 amino acids with an estimated molecular weight of approximately 50 kD (Kim2000A). The protein contains a bipartite nuclear localization signal (NLS) at the amino terminus, which is crucial for its nuclear localization (Kim2000A). The presence of the NLS ensures that SNIP1 is localized to the nucleus, as constructs lacking this signal are found in the cytoplasm (Kim2000A).

At the carboxyl terminus, SNIP1 features a Forkhead-associated (FHA) domain, which is a phosphothreonine recognition motif that may mediate protein-protein interactions (Kim2000A). Although the FHA domain is not essential for SNIP1's transcriptional inhibitory activity, it plays a role in the protein's interactions (Kim2000A).

SNIP1 interacts with several proteins, including Smad1, Smad2, Smad4, and the coactivator CBP/p300, through its amino-terminal domain (Kim2000A). These interactions are crucial for its function in suppressing TGF-β signal transduction by inhibiting the formation of Smad4/p300 complexes (Kim2000A). The protein's structure and interactions suggest a role in setting a threshold for TGF-β-induced transcriptional activation (Kim2000A).

## Function
SNIP1 (Smad nuclear interacting protein 1) is a nuclear protein that plays a significant role in regulating transcriptional processes in healthy human cells. It is involved in the TGF-β signaling pathway, where it acts as a transcriptional co-repressor by interacting with Smad proteins, particularly Smad4. SNIP1 inhibits the formation of the Smad4/p300 complex, thereby suppressing TGF-β-induced transcriptional activation, which influences cellular processes such as proliferation, differentiation, and apoptosis (Kim2000A).

SNIP1 also interacts with the transcriptional co-activator CBP/p300, modulating the transcriptional activity of target genes following ligand activation. This interaction is crucial for maintaining a balance between transcriptional activation and repression in response to TGF-β signaling (Kim2000A).

In addition to its role in TGF-β signaling, SNIP1 is involved in the regulation of c-MYC target genes and the cellular DNA damage response. It recruits TET2 to c-MYC target gene promoters, facilitating DNA demethylation and gene expression. This interaction is essential for maintaining genomic stability and protecting cells from DNA damage-induced apoptosis (Chen2018SNIP1). SNIP1's ability to bridge TET2 with transcription factors like c-MYC highlights its role in epigenetic regulation and genome integrity (Chen2018SNIP1).

## Clinical Significance
Mutations and alterations in the expression of the SNIP1 gene have been linked to several diseases and conditions. In the Amish population, a biallelic variant of SNIP1, specifically NM_024700.4:c.1097A>G, p.(Glu366Gly), causes a neurodevelopmental disorder characterized by hypotonia, developmental delay, intellectual disability, seizures, and distinct craniofacial features. This variant affects the TGF-β signaling pathway and is associated with altered gene expression profiles related to neurodevelopmental and neuropathological processes (Ammous2021A).

In non-small cell lung cancer (NSCLC), high expression levels of SNIP1 are associated with poor prognosis. SNIP1 interferes with the recruitment of HDAC1 to the RB tumor suppressor, potentially contributing to tumor progression by reducing HDAC activity and promoting cell proliferation (Jeon2013High).

In triple-negative breast cancer (TNBC), SNIP1 methylation at K301 by KMT5A promotes cancer cell growth, invasion, and metastasis by activating the YAP signaling pathway. This methylation enhances c-MYC transcriptional activity, which is crucial for tumor progression, and is associated with poor prognosis in TNBC patients (Yu2022KMT5Amethylated).

SNIP1 mutations and expression changes are also implicated in brain development disorders, where its depletion leads to increased apoptosis and brain dysplasia (Matsui2023SNIP1).

## Interactions
SNIP1 (Smad nuclear interacting protein 1) is involved in various protein interactions that influence cellular processes. It is a known interacting partner of TET2, a protein involved in DNA demethylation. SNIP1 specifically interacts with the N-terminal domain of TET2, and this interaction is crucial for regulating c-MYC target genes and the cellular DNA damage response. The interaction is specific to TET2, as SNIP1 does not interact with TET1 or TET3 (Chen2018SNIP1). SNIP1 also acts as a transcriptional co-activator, forming a ternary complex with TET2 and c-MYC, which is essential for c-MYC target gene expression (Chen2018SNIP1).

SNIP1 interacts with Smad proteins, particularly Smad4, in the context of TGF-β signaling pathways. It binds to the MH2 domain of Smad4, inhibiting the formation of the Smad4/p300 complex, thereby suppressing TGF-β-dependent transcriptional activation (Kim2000A). SNIP1 also interacts with the transcriptional co-activator CBP/p300, inhibiting its interaction with Smad4 and affecting transcriptional responses (Kim2000A).

In pancreatic ductal adenocarcinoma, SNIP1 interacts with the long non-coding RNA BCAN-AS1 through an m6A modification, which enhances the binding affinity and stabilizes c-MYC by preventing its ubiquitination (Wu2023LncRNA).


## References


[1. (Yu2022KMT5Amethylated) Bo Yu, Jun Su, Qiqi Shi, Qing Liu, Jun Ma, Guoqing Ru, Lei Zhang, Jian Zhang, Xichun Hu, and Jianming Tang. Kmt5a-methylated snip1 promotes triple-negative breast cancer metastasis by activating yap signaling. Nature Communications, April 2022. URL: http://dx.doi.org/10.1038/s41467-022-29899-w, doi:10.1038/s41467-022-29899-w. This article has 21 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-29899-w)

[2. (Ammous2021A) Zineb Ammous, Lettie E. Rawlins, Hannah Jones, Joseph S. Leslie, Olivia Wenger, Ethan Scott, Jim Deline, Tom Herr, Rebecca Evans, Angela Scheid, Joanna Kennedy, Barry A. Chioza, Ryan M. Ames, Harold E. Cross, Erik G. Puffenberger, Lorna Harries, Emma L. Baple, and Andrew H. Crosby. A biallelic snip1 amish founder variant causes a recognizable neurodevelopmental disorder. PLOS Genetics, 17(9):e1009803, September 2021. URL: http://dx.doi.org/10.1371/journal.pgen.1009803, doi:10.1371/journal.pgen.1009803. This article has 9 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1009803)

[3. (Matsui2023SNIP1) Yurika Matsui, Mohamed Nadhir Djekidel, Katherine Lindsay, Parimal Samir, Nina Connolly, Gang Wu, Xiaoyang Yang, Yiping Fan, Beisi Xu, and Jamy C. Peng. Snip1 and prc2 coordinate cell fates of neural progenitors during brain development. Nature Communications, August 2023. URL: http://dx.doi.org/10.1038/s41467-023-40487-4, doi:10.1038/s41467-023-40487-4. This article has 1 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-023-40487-4)

[4. (Kim2000A) Richard H. Kim, David Wang, Michael Tsang, Jennifer Martin, Carla Huff, Mark P. de Caestecker, W. Tony Parks, Xianwang Meng, Robert J. Lechleider, Tongwen Wang, and Anita B. Roberts. A novel smad nuclear interacting protein, snip1, suppresses p300-dependent tgf-β signal transduction. Genes &amp; Development, 14(13):1605–1616, July 2000. URL: http://dx.doi.org/10.1101/gad.14.13.1605, doi:10.1101/gad.14.13.1605. This article has 118 citations.](https://doi.org/10.1101/gad.14.13.1605)

[5. (Chen2018SNIP1) Lei-Lei Chen, Huai-Peng Lin, Wen-Jie Zhou, Chen-Xi He, Zhi-Yong Zhang, Zhou-Li Cheng, Jun-Bin Song, Peng Liu, Xin-Yu Chen, Yu-Kun Xia, Xiu-Fei Chen, Ren-Qiang Sun, Jing-Ye Zhang, Yi-Ping Sun, Lei Song, Bing-Jie Liu, Rui-Kai Du, Chen Ding, Fei Lan, Sheng-Lin Huang, Feng Zhou, Suling Liu, Yue Xiong, Dan Ye, and Kun-Liang Guan. Snip1 recruits tet2 to regulate c-myc target genes and cellular dna damage response. Cell Reports, 25(6):1485-1500.e4, November 2018. URL: http://dx.doi.org/10.1016/j.celrep.2018.10.028, doi:10.1016/j.celrep.2018.10.028. This article has 66 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2018.10.028)

[6. (Jeon2013High) Hyo-Sung Jeon, Yi Young Choi, Junya Fukuoka, Makiko Fujii, Lyudmila A. Lyakh, Sang-Hyun Song, William D. Travis, Jae Yong Park, and Jin Jen. High expression of snip1 correlates with poor prognosis in non-small cell lung cancer and snip1 interferes with the recruitment of hdac1 to rb in vitro. Lung Cancer, 82(1):24–30, October 2013. URL: http://dx.doi.org/10.1016/j.lungcan.2013.07.015, doi:10.1016/j.lungcan.2013.07.015. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.lungcan.2013.07.015)

[7. (Wu2023LncRNA) Guandi Wu, Jiachun Su, Lingxing Zeng, Shuang Deng, Xudong Huang, Ying Ye, Rui Li, Ruihong Bai, Lisha Zhuang, Mei Li, Quanbo Zhou, Yanfen Zheng, Junge Deng, Shaoping Zhang, Rufu Chen, Dongxin Lin, Jialiang Zhang, and Jian Zheng. Lncrna bcan-as1 stabilizes c-myc via n6-methyladenosine-mediated binding with snip1 to promote pancreatic cancer. Cell Death &amp; Differentiation, 30(10):2213–2230, September 2023. URL: http://dx.doi.org/10.1038/s41418-023-01225-x, doi:10.1038/s41418-023-01225-x. This article has 2 citations.](https://doi.org/10.1038/s41418-023-01225-x)